Recombinant human growth hormone - Changchun Institute of Biological Products
Latest Information Update: 08 Sep 2016
At a glance
- Originator Changchun Institute of Biological Products
- Class Growth hormones; Hormonal replacements
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Somatotropin deficiency
Most Recent Events
- 30 Aug 2016 Preclinical trials in Somatotropin deficiency in China (Injection) before August 2016 (Changchun Institute of Biological Products pipeline, August 2016)